Trial Profile
Phase II study of the combination of Cisplatin + Temozolomide in malignant glial tumours in children and adolescents at diagnosis or in relapse. CNS 2004 02.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Aug 2022
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Temozolomide (Primary)
- Indications Glioma
- Focus Therapeutic Use
- Acronyms CISTEM
- 10 Apr 2012 Actual end date Dec 2007 added as reported by ClinicalTrials.gov (NCT00147160).
- 10 Apr 2012 Actual end date Dec 2007 added as reported by ClinicalTrials.gov (NCT00147160).
- 10 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov (NCT00147160).